Web-Based Support for People With Schizophrenia and Their Families - Full Text View

Sponsored by:	National Institute of Mental Health (NIMH)
Information provided by:	National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier:	NCT00177983

Purpose

This study will assess the feasibility of using the internet and in-home computers to provide advice from health care professionals, social support, and health information to people with schizophrenia and their families.

Condition	Intervention
Relapse Rates Related to Website Usage	Behavioral: (relapse rate)

MedlinePlus related topics: Schizophrenia

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Randomized, Double-Blind, Active Control, Factorial Assignment, Efficacy Study
Official Title:	Support to Patients and Families

Further study details as provided by National Institute of Mental Health (NIMH):

Primary Outcome Measures:

The outcome, patient relapse, will be assessed for the patients in the intervention group and control group by estimating the size of the intervention's effect on relapse rate.

Secondary Outcome Measures:

For the primary caregiver, the distribution of the psychological distress measure will be examined and transformation will be made if necessary for further analysis.

Estimated Enrollment:	80
Study Start Date:	January 2003
Estimated Study Completion Date:	January 2005

Detailed Description:

The objective of this study is to assess the feasibility of using the World Wide Web (Web) and in-home computers to provide patients suffering from schizophrenia and their families advice from health care professionals, social support, and information.

The purposes of this intervention are to improve: 1) the availability, convenience and use of needed mental health services; 2) family support for their ill family members; and 3) patient and family outcomes.

Eligibility

Ages Eligible for Study:	14 Years to 55 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Diagnosis of schizophrenia Able to speak and read English Regular contact with a family member

Exclusion Criteria:

Enrolled in another study

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00177983

Locations

United States, Pennsylvania
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15261

Sponsors and Collaborators

National Institute of Mental Health (NIMH)

Investigators

Principal Investigator:

Armando J Rotondi, PhD

University of Pittsburgh

More Information

Study ID Numbers:	020774
Study First Received:	September 13, 2005
Last Updated:	February 19, 2008
ClinicalTrials.gov Identifier:	NCT00177983
Health Authority:	United States: Federal Government

Keywords provided by National Institute of Mental Health (NIMH):

Schizophrenia
Relapse
Psychological distress

Study placed in the following topic categories:

Schizophrenia
Mental Disorders
Psychotic Disorders
Schizophrenia and Disorders with Psychotic Features
Recurrence

Additional relevant MeSH terms:

Disease Attributes
Pathologic Processes

ClinicalTrials.gov processed this record on January 16, 2009